Insider · CIK 0001261974
Mary Ann Gray
director
Files at KROS (Keros Therapeutics, Inc.), RAPT (RAPT Therapeutics, Inc.), CMPX (Compass Therapeutics, Inc.), BCAB (BioAtla, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | BCAB BioAtla, Inc. | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 77,397 | Jun 18, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Common Stock | +5,250 | $0.00 | $0 | 5,250 | Jun 6, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,500 | $0.00 | $0 | 10,500 | Jun 6, 2025 |
| May 29, 2025 | RAPT RAPT Therapeutics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +257,832 | $0.00 | $0 | 257,832 | Jun 2, 2025 |
| Mar 31, 2025 | RAPT RAPT Therapeutics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +61,202 | $1.06 | $65k | 61,202 | Apr 2, 2025 |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.